BDBM377369 US10266491, Example 37::US11053197, Example 37

SMILES C=CC(=O)N(C)c1cccc(-c2ccc(C(N)=O)c3[nH]c4cc(C(C)(C)O)ccc4c23)c1

InChI Key InChIKey=JDYUDZBXVQYGPJ-UHFFFAOYSA-N

Data  6 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 6 hits for monomerid = 377369   

TargetTyrosine-protein kinase BTK(Human)
Bristol Myers Squibb

US Patent
LigandChemical structure of BindingDB Monomer ID 377369BDBM377369(US10266491, Example 37 | US11053197, Example 37)
Affinity DataIC50: 0.160nMAssay Description:To V-bottom 384-well plates were added test compounds, human recombinant Btk (1 nM, Invitrogen Corporation), fluoresceinated peptide (1.5 μM), A...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2020
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Bristol Myers Squibb

US Patent
LigandChemical structure of BindingDB Monomer ID 377369BDBM377369(US10266491, Example 37 | US11053197, Example 37)
Affinity DataIC50: 0.160nMAssay Description:To V-bottom 384-well plates were added test compounds, human recombinant Btk (1 nM, Invitrogen Corporation), fluoresceinated peptide (1.5 ATP (20 and...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/6/2022
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Bristol Myers Squibb

US Patent
LigandChemical structure of BindingDB Monomer ID 377369BDBM377369(US10266491, Example 37 | US11053197, Example 37)
Affinity DataIC50: 0.160nMAssay Description:Inhibition of recombinant human full-length His-tagged BTK cytoplasmic domain expressed in baculovirus expression system using fluorescence-labelled ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/17/2020
Entry Details Article
PubMed
TargetTyrosine-protein kinase BTK(Human)
Bristol Myers Squibb

US Patent
LigandChemical structure of BindingDB Monomer ID 377369BDBM377369(US10266491, Example 37 | US11053197, Example 37)
Affinity DataIC50: 0.160nMAssay Description:To V-bottom 384-well plates were added test compounds, human recombinant Btk (1 nM, Invitrogen Corporation), fluoresceinated peptide (1.5 μM), A...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2020
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Bristol Myers Squibb

US Patent
LigandChemical structure of BindingDB Monomer ID 377369BDBM377369(US10266491, Example 37 | US11053197, Example 37)
Affinity DataIC50: 0.160nMAssay Description:To V-bottom 384-well plates were added test compounds, human recombinant Btk (1 nM, Invitrogen Corporation), fluoresceinated peptide (1.5 ATP (20 and...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/6/2022
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Bristol Myers Squibb

US Patent
LigandChemical structure of BindingDB Monomer ID 377369BDBM377369(US10266491, Example 37 | US11053197, Example 37)
Affinity DataIC50: 23nMAssay Description:Inhibition of BTK in human Ramos cells assessed as reduction in intracellular calcium level incubated for 1 hr measured for 180 secs by FLIPR assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/17/2020
Entry Details Article
PubMed